SIRT1 and Parkinson disease: They can improve the ratio of NAD+ to NADH in the mitochondria of neurons, and increase the expression of NAD+‐dependent deacetylase sirtuin‐1 (SIRT1) in the nuclei, thereby regulating the gene expression of mitochondrial biogenesis at the transcriptional level to improve PD therapy.